SCHEMBL7244872

SCHEMBL7244872

COC(=O)c1cccc(C#C[Si](C)(C)C)c1CBr

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.38
LMNA P02545 3/20 0.38
TSHR P16473 2/20 0.37
KDM4E B2RXH2 5/20 0.37
HSD17B10 Q99714 4/20 0.36
CFTR P13569 1/20 0.36
KMT2A Q03164 3/20 0.36
POLB P06746 2/20 0.36
ATM Q13315 1/20 0.36
CYP4F2 P78329 1/20 0.35
CYP4A11 Q02928 1/20 0.35
GLA P06280 1/20 0.35
HTT P42858 1/20 0.35
TRPA1 O75762 2/20 0.34
SLC6A3 Q01959 1/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL497720 0.81 TSHR (0.49) ALDH1A1LMNATSHRKDM4EHSD17B10
SCHEMBL28641980 0.80 CA1 (0.43) ALDH1A1LMNATSHRKDM4EHSD17B10
SCHEMBL7247097 0.80 FFAR4 (0.44) ALDH1A1LMNATSHRKDM4EHSD17B10
SCHEMBL646938 0.80 ALDH1A1 (0.47) ALDH1A1LMNATSHRKDM4EHSD17B10
SCHEMBL22124364 0.79 ALDH1A1 (0.46) ALDH1A1LMNATSHRKDM4EHSD17B10
SCHEMBL29041518 0.79 LMNA (0.52) ALDH1A1LMNATSHRKDM4EHSD17B10
SCHEMBL31475519 0.74 TSHR (0.36) ALDH1A1LMNATSHRKDM4EHSD17B10
SCHEMBL17424944 0.73 LMNA (0.59) ALDH1A1LMNATSHRKDM4EHSD17B10
SCHEMBL30041782 0.73 LMNA (0.46) ALDH1A1LMNATSHRKDM4EHSD17B10
SCHEMBL5839700 0.73 ALDH1A1 (0.53) ALDH1A1LMNATSHRKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030216571-A1 Antiallergens; antiinflammatory agents UBE INDUSTRIES, LTD. (JP) 2003-11-20 US disclosed
EP-1254897-A1 TRICYCLIC COMPOUNDS Ube Industries, Ltd. (JP) 2002-11-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216571-A1 Antiallergens; antiinflammatory agents CYSLTR2, CYSLTR1, LTC4S ALDH1A1 921/4885LMNA 2810/4885TSHR 4253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.